Stallergenes Greer group

Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services.

Stallergenes Greer has an extensive global footprint and the largest allergen and finished AIT product manufacturing capacity globally. The company’s broad product portfolio, available in multiple formulations (subcutaneous, sublingual drops* and tablets), offers patients innovative solutions to improve life for people with allergies.

*Not an approved product in the US

Learn more about the Stallergenes Greer group


Last updated on: 16/11/2020

Cookies Management